These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Placement of moricizine in the selection of antiarrhythmic drug therapy. Morganroth J Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093 [TBL] [Abstract][Full Text] [Related]
8. Beta blockers in combination with class I antiarrhythmic agents. Deedwania PC; Olukotun AY; Kupersmith J; Jenkins P; Golden P Am J Cardiol; 1987 Aug; 60(6):21D-26D. PubMed ID: 2442991 [TBL] [Abstract][Full Text] [Related]
9. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079 [TBL] [Abstract][Full Text] [Related]
10. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Lazzara R Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326 [TBL] [Abstract][Full Text] [Related]
11. [Clinical use of beta-blocker an as antiarrhythmic agent]. Okazaki O; Akatsuka N Nihon Rinsho; 1996 Aug; 54(8):2117-24. PubMed ID: 8810786 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of antiarrhythmic therapy using Holter monitoring. Morganroth J Am J Cardiol; 1988 Oct; 62(12):18H-23H. PubMed ID: 3052004 [TBL] [Abstract][Full Text] [Related]
14. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias. Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmias as predictors of sudden death. Coumel P; Leclercq JF; Leenhardt A Am Heart J; 1987 Oct; 114(4 Pt 2):929-37. PubMed ID: 2889343 [TBL] [Abstract][Full Text] [Related]
16. The role of antiarrhythmic drugs in prevention of sudden cardiac death. Podrid PJ Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903 [No Abstract] [Full Text] [Related]
17. Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias. Anderson JL Am J Cardiol; 1990 Jan; 65(4):36B-42B. PubMed ID: 2105050 [TBL] [Abstract][Full Text] [Related]
18. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies. Pratt C; Lichstein E J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349 [TBL] [Abstract][Full Text] [Related]
19. COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM. Kapustnick Y; Lutsenko R; Sуdorenko A Georgian Med News; 2021 Jun; (315):85-93. PubMed ID: 34365431 [TBL] [Abstract][Full Text] [Related]
20. Overview of completed sudden death trials: US experience. Furberg CD Cardiology; 1987; 74 Suppl 2():24-31. PubMed ID: 2887288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]